Bio-IT World Weekly Update
Tuesday, March 13, 2007 |  Bio-ITWorld.com | Archives | Advertising | Your Account | CHI Conferences | Subscribe |
Sales Contacts

For advertising information contact:

Alan El Faye
VP, Ad Sales - West
213-300-3886

Jennifer McElligott
VP, Ad Sales - East
781-972-5482 

Andrew Haney
VP, Ad Sales - Northeast
781-972-1347
Reprints & ePrints

Interested in reprints of articles published in Bio-IT World magazine or one of our electronic newsletters? Contact:

Becky Mullaney
Reprint Management Services
717-399-1900 ext.166
IN THIS ISSUE 
Venter's Ocean Expedition Reports Latest Gene Haul 
Biotech Interests Give FDA an Earful Over Regulations
Connecting Computing to Science 
Lab Notebooks and Litigation 
 
THIS WEEK IN BIO-IT
 

Venter's Ocean Expedition Reports Latest Gene Haul
By Allison Proffitt

Three years after reporting the first pilot results from his Global Ocean Sampling, J. Craig Venter and colleagues have published a major new metagenomic survey of marine life. more
 

World Kidney Day's Call for Action
By Kevin Davies

A far-reaching international public relations campaign organized by the International Society of Nephrology culminated Thursday with the celebration of World Kidney Day. more
 

Bio-IT Briefs
Summaries of the latest industry news.
 
ELSEWHERE IN THE PRESS
 

Biotech Interests Give FDA an Earful Over Regulations
Companies in Silicon Valley and around the country that are pioneering personalized medicine are anxiously awaiting new regulations from the FDA that could change the way they do business. Story in the San Jose Business Journal.
 

Researchers Say FDA Increases Public Risks By Delaying Safety Data Release
Heart problems that pushed the painkillers Bextra and Vioxx off the market could have come to light earlier had federal regulators given outside researchers speedier access to raw safety data, according to a commentary written by Boston researchers. Story in The Boston Globe.
 

Connecting Computing to Science
Rick Stevens, head of Argonne National Lab's Computing and Life Sciences directorate, on the future of computational biology. Story in HPCwire.
 

When Clinical Trial Results Just Say 'No'
Biotech companies often are able to bounce back from seeming disaster, thanks to deep reserves and partnerships. Story in The San Francisco Chronicle.
 

Users Are Putting Band-Aids on Software, Says New Federal Research Chief
Jeannette Wing, who heads the computer science department at Carnegie Mellon University, sees big trouble for the U.S., private industry and users unless fundamental changes are made in the way research is done. Story in Computerworld.

Schering-Plough to Buy Akzo's Drug-Making Division for $14.4B
Schering-Plough Corp. agreed to buy Akzo Nobel NV's drug-making division Organon for $14.4 billion in cash to gain the world's third-largest maker of birth-control pills and a stable of experimental medicines. Story in Bloomberg.com.

 
 
 
BIO-IT WORLD FEBRUARY 2007
ISSUE HIGHLIGHTS
   

Lab Notebooks and Litigation
By Tom Klaff

A 2005 Atrium Research ELN report states that intellectual property generated inside a lab may be preserved anywhere from 15 to 100 years. These long-term archiving requirements, coupled with the cost to manage and store paper-based business records, can impact a company's bottom line faster and harder than a Sarbanes-Oxley investigation. more
 

The Clinical Trial Dilemma
By Robert Webber

A typical Clinical Operations group is charged with collecting myriad data points and status tracking reports, aided by specialty software applications. There are many possible approaches for data integration within these applications, and with other enterprise software, each with significant business and technical implications. So, how do the IT and clinical operations departments ensure they implement the best overall solution for the company? more
 
 
 
 
 

FEATURED EVENTS

MIT PROFESSIONAL INSTITUTE � SUMMER SESSION 2007
The Massachusetts Institute of Technology is currently accepting registrations for 36 intensive programs designed especially for
professionals. Courses are from 1 to 5 days long and are taught on campus by MIT faculty from June through August. Earn a certificate and CEUs. Offerings include biotechnology, chemical engineering, energy, data modeling and analysis, IT, lean fundamentals, mechanical engineering, nanotechnology, nuclear systems, lasers & optics, technology policy,system architecture and other topics of vital interest to today�s engineers
and scientists. Visit our website to register and view course descriptions.
http://web.mit.edu/mitpep/go/pi07-bioit.html

Post Approval Summit - April 30 - May 1, Boston, MA
Don�t miss the industry�s premier conference on post-approval research. The Post-Approval Summit at Harvard is a two day conference mapping strategies for demonstrating science, safety, and value through patient registries, phase IV studies, risk management programs, and quality initiatives.
For more information, or to register, go to www.postapproval.org

BIO International Convention - May 6 - 9, Boston, MA
Tap into the biotechnology innovations that will benefit all aspects of life on earth at the BIO International Convention at the Boston Convention and Exhibition Center May 6 9, 2007. Join 19,000 global professionals and 1,700 exhibiting companies as they converge for the most important scientific breakthroughs, trends, business opportunities, energy, agriculture, and more. http://www.bio2007.org

The 4th Annual World Health Care Congress, April 22 - 24,Washington, DC  
www.whcc2007.com
The 4th Annual World Health Care Congress, co-sponsored by The Wall Street Journal, is the most prestigious meeting of chief and senior executives from all sectors of health care. The conference will convene over 1,800 CEOs, senior executives and government officials from the nation's largest employers, hospitals, health systems, health plans, pharmaceutical and biotech companies, and leading government agencies.  Join other senior executives in creating a new healthcare model based on value, quality and consumer choice. www.whcc2007.com � 800-817-8601 � wcreg@worldcongress.com

 
 
Contact the Editor
We invite your comments and feedback for this edition of Weekly Update.

Web Editor

Cambridge Healthtech InstitutePublished by Bio-IT World Copyright � 2007, a business of Cambridge Healthtech Institute (CHI). All rights reserved. No material may be reproduced electronically or in print without written permission from Bio-IT World/CHI, 250 First Ave., Needham, MA 02494-2814. For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA; 17601 (717) 399-1900 ext. 128, or email: bemullaney@reprintbuyer.com